chr9-126614507-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001174147.2(LMX1B):c.58G>A(p.Asp20Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,455,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001174147.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMX1B | NM_001174147.2 | c.58G>A | p.Asp20Asn | missense_variant | 1/8 | ENST00000373474.9 | NP_001167618.1 | |
LMX1B | NM_001174146.2 | c.58G>A | p.Asp20Asn | missense_variant | 1/8 | NP_001167617.1 | ||
LMX1B | NM_002316.4 | c.58G>A | p.Asp20Asn | missense_variant | 1/8 | NP_002307.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMX1B | ENST00000373474.9 | c.58G>A | p.Asp20Asn | missense_variant | 1/8 | 1 | NM_001174147.2 | ENSP00000362573 | P4 | |
LMX1B | ENST00000355497.10 | c.58G>A | p.Asp20Asn | missense_variant | 1/8 | 1 | ENSP00000347684 | |||
LMX1B | ENST00000526117.6 | c.58G>A | p.Asp20Asn | missense_variant | 1/8 | 1 | ENSP00000436930 | A1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 exomes AF: 0.00000857 AC: 2AN: 233506Hom.: 0 AF XY: 0.00000782 AC XY: 1AN XY: 127836
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1455102Hom.: 0 Cov.: 31 AF XY: 0.00000691 AC XY: 5AN XY: 723416
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
LMX1B-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 09, 2023 | The LMX1B c.58G>A variant is predicted to result in the amino acid substitution p.Asp20Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0019% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-129376786-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 20 of the LMX1B protein (p.Asp20Asn). This variant is present in population databases (rs758741262, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with LMX1B-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at